hapabapa
Yield10 Bioscience (NASDAQ:YTEN) said it is waiting for a Nasdaq panel to determine whether it will be granted an additional time extension to regain compliance with the exchange’s listing requirements.
The agricultural biotech company said that it participated in a Nasdaq hearing on the matter on Feb. 6, with a decision expected within the next month.
Yield 10 also said that it intends to prioritize advancing its Omega-3 Camelina product towards commercialization. The company said it has completed contra season production in Chile of the agricultural product, which produces a component of the omega-3 oil found in fish.